Pharmacometric Models to Improve Treatment of Tuberculosis
Tuberculosis (TB) is the world’s most deadly infectious disease and causes enormous public health problems. The comorbidity with HIV and the rise of multidrug-resistant TB strains impede successful therapy through drug-drug interactions and the lack of efficient second-line treatments. The aim of th...
Main Author: | Svensson, Elin M |
---|---|
Format: | Doctoral Thesis |
Language: | English |
Published: |
Uppsala universitet, Institutionen för farmaceutisk biovetenskap
2016
|
Subjects: | |
Online Access: | http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-282139 http://nbn-resolving.de/urn:isbn:978-91-554-9539-8 |
Similar Items
-
Efficacy of bedaquiline in the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis
by: Ming-Gui Wang, et al.
Published: (2021-09-01) -
Bedaquiline in the multidrug-resistant tuberculosis treatment: Belarus experience
by: Alena Skrahina, et al.
Published: (2016-01-01) -
Novel Pharmacometric Methods for Informed Tuberculosis Drug Development
by: Clewe, Oskar
Published: (2016) -
Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Children: The Role of Bedaquiline and Delamanid
by: Francesco Pecora, et al.
Published: (2021-05-01) -
Bedaquiline for multidrug-resistant tuberculosis and QTc prolongation in California
by: Shereen Katrak, et al.
Published: (2021-05-01)